Russell 1000 Dividend Hits $125 as J&J Leads the Safety Test
The SPDR Russell 1000 Yield Focus ETF nears a $125 price point, anchored by Johnson & Johnson and other blue-chip div...
Daily monitoring turns awareness into savings. This intro highlights simple routines to track spending and reinforce smart choices.
20,684 articlesThe SPDR Russell 1000 Yield Focus ETF nears a $125 price point, anchored by Johnson & Johnson and other blue-chip div...
A fresh study links childhood money beliefs to adult investing behavior, prompting a shift toward mindset-first finan...
A leading blockchain investigator ties a US-based actor to a $19 million crypto theft network that used social engine...
EWZ’s semi-annual payouts are highly dependent on Petrobras and Vale, delivering big checks in buoyant commodity mark...
Explore Innoviz's path in 2026 with a deep dive into Q1 results, margins, backlog, and strategic bets. This analysis ...
Douglas Elliman expands into New Hampshire, recruiting Adam Pettitt to The Sarkis Team and debuting LOOKOUT Lake Winn...
Hyperliquid's AQAv2 upgrade pushes HYPE higher as Coinbase and Circle commit to the new stablecoin framework, alignin...
Stocks waver as the 10-Year Treasury yield breaks higher, pushing mortgage rates headed higher. Analysts warn borrowe...
P3 Health is shaping the future of value-based care with its platform. This guide breaks down what to expect from hea...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Imagine income investments that don’t just pay a dividend, they propel total returns. This article highlights three d...
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...